About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer...
The University Hospital Ulm and its employees stand for a modern and high quality patient care, excellent university research and medical education focused on the future as well as apprenticeships in attractive professional fields. The requirements f...
(Senior) Research Associate - Immuno-Oncology (gn)
About us
iOmx Therapeutics is a clinical-stage company in the field of immuno-oncology located in Martinsried/Munich, Germany. We are focusing on the development of first-in-class cancer immunot...
Aufgaben:
The laboratory of Epigenetics of Aging at TUM Garching seeks to recruit a qualified candidate with a deep commitment to basic research TVL-E13/60%) for participation in a research project starting April-May 2024.
We are seeking a high...
The University Hospital Ulm and its employees stand for a modern and high quality patient care, excellent university research and medical education focused on the future as well as apprenticeships in attractive professional fields. The requirements f...
We are the Klinikum rechts der Isar (MRI), Hospital of Munich Technical University (TUM), and a reliable employer of around 6,600 people. Being a university hospital, we not only look after our patients but, based on our motto “Knowledge Creates C...
Research assistant position (m/f/d) in the context of a third-party-funded project for radiation induced gene expression measurements in saliva and blood
Institution
The Bundeswehr guarantees the security, sovereignty, and foreign policy capabi...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
